In 2023, the number of new clinically diagnosed pulmonary tuberculosis cases in the US was 840. The forecast indicates a downward trend through 2028, with the cases decreasing each year: 2024 sees 815 cases, declining to 721 by 2028. Year-on-year, this represents a decrease in cases by approximately 2.9% from 2024 to 2025, 3.0% from 2025 to 2026, 3.0% from 2026 to 2027, and 3.1% from 2027 to 2028. The five-year compound annual growth rate (CAGR) suggests an average annual reduction of approximately 2.9%.
Future trends to watch for include advancements in public health strategies and treatments that could further reduce tuberculosis cases, as well as potential challenges such as drug-resistant strains. Monitoring vaccination programs and public awareness campaigns will be crucial in maintaining and accelerating the decline in new cases.
